Intrathecal miR-183 delivery suppresses mechanical allodynia in mononeuropathic rats
Related Experiment Video
Updated: May 2, 2026

The Sciatic Nerve Cuffing Model of Neuropathic Pain in Mice
Published on: July 16, 2014
Chung-Ren Lin1, Kuan-Hung Chen, Chien-Hui Yang
1Department of Anesthesiology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, No. 123 Dapi Rd, Kaohsiung, 833, Taiwan; Department of Anesthesiology, National Taiwan University College of Medicine, Taipei, Taiwan.
Abstract:
Members of the miR-183 family are unique in that they are highly abundant in sensory organs. In a recent study, significant downregulation was observed for miR-96 and miR-183 in the L5 dorsal root ganglion (DRG) 2 weeks after spinal nerve ligation (SNL). In this study, we focused on miR-183, which is the most regulated member of the miR-183 family, to look at the specific role on neuropathic pain. Persistent mechanical allodynia was induced with the L5 SNL model in 8-week-old male Sprague-Dawley rats. Paw withdrawal thresholds in response to mechanical stimuli were assessed with Von Frey filaments. Expression of miR-183 in the L5 DRG was assessed with quantitative real-time polymerase chain reaction (qPCR) analysis. Lentivirions expressing miR-183 were injected intrathecally into SNL rats. Changes in mechanical allodynia were assessed with Von Frey filaments. In addition, changes in the predicted target genes of miR-183 were assessed with qPCR. L5 SNL produced marked mechanical allodynia in the ipsilateral hindpaws of adult rats, beginning at postoperative day 1 and continuing to day 14. L5 SNL caused significant downregulation of miR-183 in adult DRG cells. Intrathecal administration of lentivirions expressing miR-183 downregulated SNL-induced increases in the expression of Nav1.3 and brain-derived neurotrophic factor (BDNF), which correlated with the significant attenuation of SNL-induced mechanical allodynia. Our results show that SNL-induced mechanical allodynia is significantly correlated with the decreased expression of miR-183 in DRG cells. Replacement of miR-183 downregulates SNL-induced increases in Nav1.3 and BDNF expression, and attenuates SNL-induced mechanical allodynia.
Insights
Neuropathic pain is linked to reduced miR-183 in dorsal root ganglion (DRG) cells. Restoring miR-183 levels alleviates pain and downregulates key pain-related genes, offering a potential therapeutic target.
Area of Science:
- Neuroscience
- Molecular Biology
- Pain Research
Background:
- MicroRNAs (miRNAs) are key regulators of gene expression.
- The miR-183 family is abundant in sensory organs.
- Previous studies indicated downregulation of miR-96 and miR-183 in dorsal root ganglia (DRG) after spinal nerve ligation (SNL).
Purpose of the Study:
- To investigate the specific role of miR-183 in neuropathic pain.
- To determine if miR-183 downregulation correlates with mechanical allodynia.
- To assess the therapeutic potential of restoring miR-183 levels.
Main Methods:
- Established a rat model of neuropathic pain using L5 spinal nerve ligation (SNL).
- Quantified miR-183 expression in L5 DRG using quantitative real-time polymerase chain reaction (qPCR).
- Administered lentiviral vectors expressing miR-183 intrathecally and assessed changes in mechanical allodynia and target gene expression (Nav1.3, BDNF) via qPCR.
Main Results:
- L5 SNL induced persistent mechanical allodynia in rats.
- SNL significantly downregulated miR-183 expression in L5 DRG cells.
- Intrathecal miR-183 delivery attenuated mechanical allodynia and reduced Nav1.3 and BDNF expression.
Conclusions:
- SNL-induced mechanical allodynia is associated with decreased miR-183 expression in DRG.
- Restoring miR-183 levels effectively reduces neuropathic pain behaviors.
- miR-183 may exert its analgesic effect by downregulating Nav1.3 and BDNF.
More Related Videos
05:24In Vivo SiRNA Transfection and Gene Knockdown in Spinal Cord via Rapid Noninvasive Lumbar Intrathecal Injections in Mice
Published on: March 22, 2014
08:16Partial Sciatic Nerve Ligation: A Mouse Model of Chronic Neuropathic Pain to Study the Antinociceptive Effect of Novel Therapies
Published on: October 6, 2022